Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
Sanada
Shoji
S
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan.
Asanuma
Hiroshi
H
Minamino
Tetsuo
T
Node
Koichi
K
Takashima
Seiji
S
Okuda
Hiroko
H
Shinozaki
Yoshiro
Y
Ogai
Akiko
A
Fujita
Masashi
M
Hirata
Akio
A
Kim
Jiyoong
J
Asano
Yoshihiro
Y
Mori
Hidezo
H
Tomoike
Hitonobu
H
Kitamura
Soichiro
S
Hori
Masatsugu
M
Kitakaze
Masafumi
M
D015720:5'-Nucleotidase / Q000502:physiology*; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology; D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002867:Chromones / Q000494:pharmacology; D003327:Coronary Disease / Q000150:complications*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009025:Morpholines / Q000494:pharmacology; D009203:Myocardial Infarction / Q000209:etiology / Q000473:pathology*; D015428:Myocardial Reperfusion Injury / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology*; D000081082:Phosphoinositide-3 Kinase Inhibitors; D017035:Pravastatin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011804:Quinolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology; D000077191:Wortmannin
D015720:5'-Nucleotidase; D000255:Adenosine Triphosphate; D000730:Androstadienes; D002316:Cardiotonic Agents; D002867:Chromones; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D017035:Pravastatin; D011725:Pyridines; D011804:Quinolines; D013806:Theophylline; D000077191:Wortmannin; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; C031433:8-(4-sulfophenyl)theophylline; C086276:cerivastatin; C108475:pitavastatin; C002630:alpha,beta-methyleneadenosine 5'-triphosphate